港股创新药概念股持续走低，诺诚健华、荣昌生物跌超10%

Core Viewpoint - The Hong Kong stock market for innovative drug concept stocks continues to decline, with significant drops in several companies' stock prices [1] Company Performance - Innovent Biologics (诺诚健华) and Rongchang Biopharmaceutical (荣昌生物) both experienced declines exceeding 10% [1] - Genscript Biotech (歌礼制药-B) saw a drop of over 8% [1] - Other companies such as Kanglong Chemical (康龙化成) and WuXi Biologics (药明生物) also reported notable declines in their stock prices [1]